Translation for information purpose only INVENTIVA French soci t Anonyme with a Board of Directors with a share capital of EUR 421,341.69 Registered Office: 50, Rue de Dijon, 21121 Daix 537 530 255 Trade and Companies Re

Translation for information purpose only

French soci t Anonyme with

a Board of Directors

with a share capital of EUR 421,341.69

Registered Office: 50, Rue de Dijon, 21121 Daix

537 530 255 Trade and Companies Register of Dijon

The shareholders of INVENTIVA are informed that

the Ordinary and Extraordinary General Meeting will be held on May 25, 2023 at 2 p.m., at: H tel Oceania Le Jura - 14

avenue Foch - 21000 Dijon, France.

As a reminder, the agenda of the General Meeting,

unchanged from that published in the notice of the General Meeting published in the Bulletin des Annonces L gales Obligatoires

on April 17th, 2023 (bulletin n 46), is as follows:

Reading of the reports of the Board of Directors

and the Statutory Auditors ;

On an Ordinary basis

On an Extraordinary basis

On an Ordinary basis

The draft resolutions to be submitted to the vote

of the General Meeting were published in the meeting notice of the Bulletin des Annonces L gales Obligatoires on April 17th,

2023 (bulletin n 46) and remain unchanged.

Translation for information purpose only

Pursuant to Article R. 22-10-28 of the French

Commercial Code, will be able to participate in the General Meeting, the shareholders who will justify:

Only those shareholders who can prove their status

by or before Tuesday, May 23rd , 2023, zero hour, Paris time, under the conditions set out above, will be able to participate

in this General Meeting.

Method of participation in the Shareholders'

Shareholders have several options for participating

in the General Meeting. They can (1) vote while physically attending the General Meeting or (2) vote remotely or by proxy (a) by

mail or (b) via Internet.

Pursuant to the provisions of Article R.

22-10-28, III, of the French Commercial Code, once a shareholder votes remotely, sends a proxy or asks for an admission card or a

certificate to participate in the General Meeting, he or she will not be able to choose another method of participation.

The shareholders wishing to personally attend

the General Meeting must request an admission card as soon as possible to receive the card in a timely manner:

On the day of the General Meeting, each shareholder

will have to prove her quality during the registration process.

Translation for information purpose only

The shareholders not physically attending the

General Meeting will be able to vote remotely or to give proxy to the President of the General Meeting, to their spouse, to their partner

with whom a pacte civil de solidarit has been made, to another shareholder or to any other individual or legal entity of

their choosing, subject to the conditions set forth in Articles L. 225-106 and L. 22-10-30 of the French Commercial Code.

Pursuant to the provisions of Article R.

225-79 of the French Commercial Code, the proxy given by a shareholder to be represented must be signed by the shareholder. The proxy

will specify his/her last name, first name and address, and will designate a proxy, including his/her last name, first name and address

or for a legal entity, its corporate name and registered office. The proxy does not have the right delegate its duties to another individual

It is specified that, for any proxy without indication

of an agent, the President of the General Meeting will vote in favor of adopting the draft resolutions presented or approved to by the

Board of Directors and vote against adopting all other draft resolutions. To vote otherwise, the shareholders will have to designate an

agent who will accept to vote as provided by the principal.

For registered shareholders: a postal voting

form or proxy form will be sent directly to them. This form should be returned in the prepaid T envelope enclosed with the notice of meeting.

For holders of bearer shares: from this

day, the postal voting form or proxy form can be requested from the intermediaries managing their shares. Each demand must be addressed

by the financial intermediary to the Services des Assembl es of Soci t G n rale, 32, rue du

Champs de Tir, CS 30812, 44308 Nantes Cedex 3 at the latest six days before the date of the General Meeting (Article R. 225-75 of

the French Commercial Code). The single postal voting form or proxy form must be submitted with a certificate of securities ownership

drawn up by the financial intermediary who will have to forward these documents to the Services des Assembl es of Soci t

G n rale, 32, rue du Champs de Tir, CS 30812, 44308 Nantes Cedex 3.

In any case, the postal voting form or proxy voting

form duly filled and signed (and accompanied by the certificate of securities ownership for the bearer shares) must be returned in such

a way that the Services des Assembl es of Soci t G n rale or the Company can receive it at

least 3 days before the date of the General Meeting (that is Monday, May 22th, 2023).

Shareholders also have the option of transmitting

their voting instructions and giving or revoking a proxy via Internet before the General Meeting, on the website Votaccess, under the

following conditions:

they also may give or revoke a proxy

by sending an e-mail with an electronic signature, obtained by them from a third party certifier duly authorized pursuant to legal and

regulatory provisions in force, to the electronic address Agiva25052023@inventivapharma.com specifying, as for pure registered shareholders,

their name, first name, address and their Soci t G n rale access code (information available at the top left

of their account statement), or, as for administered registered shareholders, their access code with their authorized intermediary, as

well as the name, first name and address of the appointed or revoked agent;

For any request, SGSS is available to

shareholders from 9:30 a.m. to 6:00 p.m. on the following telephone number: + 33 (0)2 51 85 67 89;

Translation for information purpose only

Beware, only those shareholders whose

account holder has subscribed to Votaccess will be able to vote, give or revoke a proxy via Internet.

If the account holder of the shareholder

has not subscribed to Votaccess, the notice of appointment and revocation of a proxy can nevertheless be effectuated by electronic means

in accordance with the provisions of Articles R. 22-10-24 and R. 225-79 of the French Commercial Code according to the following procedures:

by sending an e-mail with an electronic signature, obtained by them from a third party certifier duly authorized pursuant to legal and

regulatory provisions in force, to the electronic address Agiva25052023@inventivapharma.com specifying their last name, first name, address,

and their share-account's full bank references, as well as the last name, first name and address of the appointed or revoked agent, and

then by asking imperatively to the authorized intermediary managing their share-accounts to send a written confirmation to the Services

des Assembl es of Soci t G n rale.

In order for the duly signed and completed appointments

or revocations of proxy to be validly taken into account, they must reach the Company no later than Monday, May 22th,

The revocation of a proxy is carried out under

the same conditions of form as those used for its appointment.

The secured platform Votaccess will be open as

of Friday, May 5th, 2023, 9 a.m., Paris time. The ability to vote, give or revoke a proxy via Internet prior to the General

Meeting will end on Wednesday, May 24th, 2023, 3 p.m., Paris time. Shareholders are advised not to wait until the last

days before the General Meeting to enter their instructions.

You are reminded that, in accordance with the

provisions of Article R. 22-10-28 of the French Commercial Code:

Submission of written questions

In accordance with the provisions of Article R.

225-84 of the French Commercial Code, each shareholder will have the right to submit written questions to the Board of Directors no later

than the fourth (4th) business day preceding the date of the Shareholders' Meeting, i.e. Friday, May 19th,